New patent expiration for Galderma Labs drug ORACEA
Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one […]
New patent expiration for Galderma Labs drug ORACEA Read Post »
Patent Expiration
Drug Patent Expirations for the Week of March 31, 2024
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of March 31, 2024 Read Post »
New patent expiration for Merck Sharp drug DUTREBIS
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
New patent expiration for Msd Sub drug ISENTRESS HD
Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in
New patent expiration for Msd Sub drug ISENTRESS HD Read Post »
New patent expiration for Otter Pharms drug SYMPAZAN
Annual Drug Patent Expirations for SYMPAZAN Sympazan is a drug marketed by Otter Pharms and is included in one NDA.
New patent expiration for Otter Pharms drug SYMPAZAN Read Post »
New patent expiration for Sumitomo Pharma drug KYNMOBI
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sumitomo Pharma Am and is included in one
New patent expiration for Sumitomo Pharma drug KYNMOBI Read Post »
New patent expiration for Msd Sub drug ISENTRESS
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three
New patent expiration for Msd Sub drug ISENTRESS Read Post »
New patent expiration for Indivior drug SUBOXONE
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior and is included in two NDAs. It
New patent expiration for Indivior drug SUBOXONE Read Post »
New patent expiration for Aquestive drug EXSERVAN
Annual Drug Patent Expirations for EXSERVAN Exservan is a drug marketed by Aquestive and is included in one NDA. It
New patent expiration for Aquestive drug EXSERVAN Read Post »
